3/17
11:37 am
acxp
Is Acurx Pharmaceuticals (ACXP) Outperforming Other Medical Stocks This Year? [Yahoo! Finance]
Medium
Report
Is Acurx Pharmaceuticals (ACXP) Outperforming Other Medical Stocks This Year? [Yahoo! Finance]
3/13
01:03 pm
acxp
Acurx Pharmaceuticals, Inc. (ACXP) Q4 2025 Earnings Call Transcript [Seeking Alpha]
Medium
Report
Acurx Pharmaceuticals, Inc. (ACXP) Q4 2025 Earnings Call Transcript [Seeking Alpha]
3/13
07:01 am
acxp
Acurx Pharmaceuticals, Inc. Reports Full Year and Fourth Quarter Results and Provides Business Update
High
Report
Acurx Pharmaceuticals, Inc. Reports Full Year and Fourth Quarter Results and Provides Business Update
3/11
03:52 pm
acxp
Acurx Pharmaceuticals, Inc. [CNN]
Low
Report
Acurx Pharmaceuticals, Inc. [CNN]
3/9
08:10 am
acxp
Acurx Announces New Ibezapolstat Clinical Trial Program in Patients with Recurrent CDI That Has the Potential to Shift the Paradigm of Treatment and Prevention of C. difficile Infection [Yahoo! Finance]
High
Report
Acurx Announces New Ibezapolstat Clinical Trial Program in Patients with Recurrent CDI That Has the Potential to Shift the Paradigm of Treatment and Prevention of C. difficile Infection [Yahoo! Finance]
3/9
08:01 am
acxp
Acurx Announces New Ibezapolstat Clinical Trial Program in Patients with Recurrent CDI That Has the Potential to Shift the Paradigm of Treatment and Prevention of C. difficile Infection
High
Report
Acurx Announces New Ibezapolstat Clinical Trial Program in Patients with Recurrent CDI That Has the Potential to Shift the Paradigm of Treatment and Prevention of C. difficile Infection
2/24
01:29 pm
acxp
Acurx Pharmaceuticals (ACXP) Secures New US Patent for DNA Polymerase IIIC Inhibitors [Yahoo! Finance]
Low
Report
Acurx Pharmaceuticals (ACXP) Secures New US Patent for DNA Polymerase IIIC Inhibitors [Yahoo! Finance]
2/16
08:10 am
acxp
Acurx Pharmaceuticals to Discuss Full Year and Fourth Quarter 2025 Financial Results on March 13, 2026 Conference Call and Provide Business Update [Yahoo! Finance]
Low
Report
Acurx Pharmaceuticals to Discuss Full Year and Fourth Quarter 2025 Financial Results on March 13, 2026 Conference Call and Provide Business Update [Yahoo! Finance]
2/16
08:01 am
acxp
Acurx Pharmaceuticals to Discuss Full Year and Fourth Quarter 2025 Financial Results on March 13, 2026 Conference Call and Provide Business Update
Low
Report
Acurx Pharmaceuticals to Discuss Full Year and Fourth Quarter 2025 Financial Results on March 13, 2026 Conference Call and Provide Business Update
2/2
08:33 am
acxp
USPTO Grants Acurx Pharmaceuticals New Patent for DNA Polymerase IIIC Inhibitors [Yahoo! Finance]
Low
Report
USPTO Grants Acurx Pharmaceuticals New Patent for DNA Polymerase IIIC Inhibitors [Yahoo! Finance]
2/2
08:00 am
acxp
USPTO Grants Acurx Pharmaceuticals New Patent for DNA Polymerase IIIC Inhibitors
Medium
Report
USPTO Grants Acurx Pharmaceuticals New Patent for DNA Polymerase IIIC Inhibitors
12/28
01:08 am
acxp
Acurx Pharmaceuticals (NASDAQ:ACXP) was upgraded by analysts at
Wall Str
Medium
Report
Acurx Pharmaceuticals (NASDAQ:ACXP) was upgraded by analysts at
Wall Str
12/20
01:30 am
acxp
Acurx Pharmaceuticals (NASDAQ:ACXP) was downgraded by analysts at
Wall S
Low
Report
Acurx Pharmaceuticals (NASDAQ:ACXP) was downgraded by analysts at
Wall S